Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates.
作者信息
Kolibab Kristopher, Derrick Steven C, Morris Sheldon L
出版信息
J Clin Microbiol. 2011 Jun;49(6):2380-1. doi: 10.1128/JCM.00648-11. Epub 2011 Apr 20.
Abstract
摘要
相似文献
1
Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates.牛分枝杆菌卡介苗菌株和播散性卡介苗病分离株对异烟肼的敏感性
J Clin Microbiol. 2011 Jun;49(6):2380-1. doi: 10.1128/JCM.00648-11. Epub 2011 Apr 20.
2
Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.牛分枝杆菌卡介苗蒙特利尔菌株的抗结核药物敏感性试验。
Can J Microbiol. 1990 Oct;36(10):735-7. doi: 10.1139/m90-125.
3
4
Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.inhA（而非kasA）的过表达赋予耻垢分枝杆菌、牛型结核分枝杆菌卡介苗和结核分枝杆菌对异烟肼和乙硫异烟胺的抗性。
Mol Microbiol. 2002 Oct;46(2):453-66. doi: 10.1046/j.1365-2958.2002.03162.x.
5
Genotyping and rifampicin and isoniazid resistance in Mycobacterium bovis strains isolated from the lymph nodes of slaughtered cattle.从屠宰牛淋巴结分离出的牛分枝杆菌菌株的基因分型及对利福平和异烟肼的耐药性
Tuberculosis (Edinb). 2017 May;104:30-37. doi: 10.1016/j.tube.2017.02.006. Epub 2017 Feb 21.
6
7
In vitro susceptibility of Mycobacterium bovis against moxifloxacin.牛分枝杆菌对莫西沙星的体外敏感性
Int J Tuberc Lung Dis. 2012 Nov;16(11):1562. doi: 10.5588/ijtld.12.0042.
8
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.牛分枝杆菌卡介苗疫苗株对抗结核抗生素的敏感性。
Antimicrob Agents Chemother. 2009 Jan;53(1):316-8. doi: 10.1128/AAC.01302-08. Epub 2008 Oct 27.
9
Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.牛分枝杆菌疾病中的原发性异烟肼耐药性：一个值得关注的问题。
Am J Respir Crit Care Med. 2012 Jul 1;186(1):110-1. doi: 10.1164/ajrccm.186.1.110.
10
[Antitubercular effect of capreomycin in vitro].卷曲霉素的体外抗结核作用
Gruzlica. 1969 Jul;37(7):629-35.
引用本文的文献
1
A feasibility study of controlled human infection with intradermal Bacillus Calmette-Guérin (BCG) injection: Pilot BCG controlled human infection model.皮内注射卡介苗（BCG）进行人体感染控制的可行性研究：卡介苗人体感染控制试验模型。
Wellcome Open Res. 2024 Jun 5;8:424. doi: 10.12688/wellcomeopenres.19811.2. eCollection 2023.
2
Characterization of spectinamide 1599 efficacy against different mycobacterial phenotypes.研究 spectinamide 1599 对不同分枝杆菌表型的疗效。
Tuberculosis (Edinb). 2023 May;140:102342. doi: 10.1016/j.tube.2023.102342. Epub 2023 Apr 20.
3
An Updated Review on MSMD Research Globally and A Literature Review on the Molecular Findings, Clinical Manifestations, and Treatment Approaches in China.全球 MSMD 研究的最新综述及中国在分子发现、临床表现和治疗方法方面的文献综述
Front Immunol. 2022 Jul 18;13:926781. doi: 10.3389/fimmu.2022.926781. eCollection 2022.
4
A Rapid Unraveling of the Activity and Antibiotic Susceptibility of Mycobacteria.分枝杆菌活性和抗生素敏感性的快速消退。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02194-18. Print 2019 Mar.
5
CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.儿童局部卡介苗不良反应的临床管理
Rev Inst Med Trop Sao Paulo. 2016 Nov 3;58:84. doi: 10.1590/S1678-9946201658084.
6
Tuberculosis in infants: a retrospective study in China.婴儿结核病：一项在中国的回顾性研究。
Springerplus. 2016 Apr 27;5:546. doi: 10.1186/s40064-016-2184-7. eCollection 2016.
7
Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.全球卡介苗疫苗株集合的基因组表达目录显示出高度分化的代谢和细胞壁适应性的证据。
Sci Rep. 2015 Oct 21;5:15443. doi: 10.1038/srep15443.
8
Clinical and laboratory observation of Bacillus Calmette-Guérin infections.卡介苗感染的临床与实验室观察
Int J Clin Exp Med. 2015 Jun 15;8(6):10099-104. eCollection 2015.
9
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.结核分枝杆菌复合群内遗传多样性对新型抗生素的开发和耐药性诊断检测的重要性。
Antimicrob Agents Chemother. 2012 Dec;56(12):6080-7. doi: 10.1128/AAC.01641-12. Epub 2012 Sep 24.
本文引用的文献
1
Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses.膀胱内治疗浅表性膀胱癌：随机试验和荟萃分析的系统评价。
Cancer Treat Rev. 2010 May;36(3):195-205. doi: 10.1016/j.ctrv.2009.12.005. Epub 2010 Jan 15.
2
Extensively drug-resistant tuberculosis.广泛耐药结核病
Curr Opin Infect Dis. 2009 Apr;22(2):167-73. doi: 10.1097/qco.0b013e3283229fab.
3
Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.4例膀胱癌患者在膀胱内灌注卡介苗后发生播散性牛分枝杆菌感染。
South Med J. 2008 Jan;101(1):91-5. doi: 10.1097/SMJ.0b013e31815d4047.
4
Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.多重耐药和广泛耐药结核分枝杆菌：流行病学与防控
Expert Rev Anti Infect Ther. 2007 Oct;5(5):857-71. doi: 10.1586/14787210.5.5.857.
5
Laboratory diagnostic aspects of drug resistant tuberculosis.耐药结核病的实验室诊断方面
Front Biosci. 2004 Sep 1;9:2086-105. doi: 10.2741/1290.
6
A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927.1927年后获得的卡介苗菌株中，mma3基因的一个点突变导致甲氧基分枝菌酸生成受损。
J Bacteriol. 2000 Jun;182(12):3394-9. doi: 10.1128/JB.182.12.3394-3399.2000.
7
Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.卡介苗膀胱内灌注治疗后，牛分枝杆菌卡介苗引发脊椎骨髓炎（波特氏病）。
J Clin Microbiol. 1999 Jun;37(6):2106-8. doi: 10.1128/JCM.37.6.2106-2108.1999.
8
Drug therapy of bacillus Calmette-Guérin sepsis.卡介苗败血症的药物治疗。
Urol Res. 1995;22(6):373-6. doi: 10.1007/BF00296878.
Zotero 插件